These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8291408)
1. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Kjaersgaard-Andersen P; Nafei A; Teichert G; Kristensen O; Schmidt SA; Keller J; Lucht U Acta Orthop Scand; 1993 Dec; 64(6):639-42. PubMed ID: 8291408 [TBL] [Abstract][Full Text] [Related]
2. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. Schmidt SA; Kjaersgaard-Andersen P; Pedersen NW; Kristensen SS; Pedersen P; Nielsen JB J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359 [TBL] [Abstract][Full Text] [Related]
3. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis]. Hochheim B; Wünsche F Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436 [TBL] [Abstract][Full Text] [Related]
4. Short term prophylaxis against heterotopic bone after cementless hip replacement. Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911 [TBL] [Abstract][Full Text] [Related]
5. Naproxen in the prevention of heterotopic ossification after total hip replacement. Vielpeau C; Joubert JM; Hulet C Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883 [TBL] [Abstract][Full Text] [Related]
6. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. Cella JP; Salvati EA; Sculco TP J Arthroplasty; 1988; 3(3):229-34. PubMed ID: 3141590 [TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report. Kjaersgaard-Andersen P; Ritter MA Clin Orthop Relat Res; 1992 Jun; (279):157-62. PubMed ID: 1600651 [TBL] [Abstract][Full Text] [Related]
8. Indomethacin for prevention of heterotopic ossification after total hip arthroplasty. Tözün R; Pinar H; Yeşiller E; Hamzaoğlu A J Arthroplasty; 1992 Mar; 7(1):57-61. PubMed ID: 1564466 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin for prevention of ectopic ossification after hip arthroplasty. Kjaersgaard-Andersen P; Schmidt SA Acta Orthop Scand; 1986 Feb; 57(1):12-4. PubMed ID: 3083642 [TBL] [Abstract][Full Text] [Related]
10. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. McMahon JS; Waddell JP; Morton J J Arthroplasty; 1991 Sep; 6(3):259-64. PubMed ID: 1940932 [TBL] [Abstract][Full Text] [Related]
11. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips. Gebuhr P; Sletgård J; Dalsgård J; Soelberg M; Keisu K; Hänninen A; Crawford M Acta Orthop Scand; 1996 Feb; 67(1):29-32. PubMed ID: 8615097 [TBL] [Abstract][Full Text] [Related]
12. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398 [TBL] [Abstract][Full Text] [Related]
13. Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen. Sodemann B; Persson PE; Nilsson OS Arch Orthop Trauma Surg (1978); 1988; 107(6):329-33. PubMed ID: 3149179 [TBL] [Abstract][Full Text] [Related]
14. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Grohs JG; Schmidt M; Wanivenhaus A Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399 [TBL] [Abstract][Full Text] [Related]
15. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation]. Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851 [TBL] [Abstract][Full Text] [Related]
16. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification. Kjaersgaard-Andersen P; Schmidt SA Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640 [TBL] [Abstract][Full Text] [Related]
17. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy. Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751 [TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty. Kjaersgaard-Andersen P; Schmidt SA; Pedersen NW; Kristensen SS; Pedersen P Clin Orthop Relat Res; 1989 Nov; (248):189-94. PubMed ID: 2509120 [TBL] [Abstract][Full Text] [Related]
19. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty. Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094 [TBL] [Abstract][Full Text] [Related]
20. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. Burd TA; Lowry KJ; Anglen JO J Bone Joint Surg Am; 2001 Dec; 83(12):1783-8. PubMed ID: 11741055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]